Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
10 pending office actions • 5 art units • 9 examiners • 0 of 10 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Uti Limited Partnership manages a portfolio containing 11 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 10 distinct examiners and 6 distinct art units. This distribution indicates a broad prosecution effort that spans multiple specialized groups at the patent office. The variety of art units suggests that the underlying technology is diverse enough to require review from several different examination teams.
DIBRINO, MARIANNE is identified as the busiest examiner for this company. This examiner is currently responsible for 2 pending office actions. The presence of 10 distinct examiners for 11 pending actions shows that almost every case is being handled by a different individual. This decentralized approach means that prosecution outcomes are influenced by a wide range of examiner-specific practices. Furthermore, the presence of 6 distinct art units confirms that the company's intellectual property covers a wide variety of technical sub-fields within the pharmaceutical sector. Practitioners should be prepared for varying timelines and requirements across these 6 distinct art units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (20%) |
| §103 only | 2 (20%) |
| Multi-statute (no §101) | 6 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DIBRINO, MARIANNE | 2 | 42.8% | +42.2% |
| MOORE, WHITNEY | 1 | 88.1% | +10.1% |
| VU, QUYNH-NHU HOANG | 1 | 68.5% | +27.4% |
| HAILEY, PATRICIA L | 1 | 88.1% | +10.1% |
| WITHERSPOON, SIKARL A | 1 | 86.2% | -20.1% |
| JONES, KOLTON ED | 1 | — | — |
| JOHNSON, CHRISTOPHER LINDSAY | 1 | 46.9% | +81.0% |
| WOITACH, JOSEPH T | 1 | 49.9% | +28.3% |
| SABILA, MERCY HELLEN | 1 | 57.0% | +46.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18290692 | METAL ORGANIC FRAMEWORK FILM AND METHOD OF MAKING | WITHERSPOON, SIKARL A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18026397 | METHODS OF TREATING AND/OR PREVENTING ALZHEIMER’S DISEASE WITH R-CARVEDILOL | JOHNSON, CHRISTOPHER LINDSAY | 66d overdue |
| 18744298 | SYSTEM AND METHOD FOR GLOBAL REAL-TIME KINEMATIC PRECISE POSITIONING | MOORE, WHITNEY | — |
| 18701047 | MICRONEEDLE AND ARRAY AND METHOD OF FABRICATING SAME | VU, QUYNH-NHU HOANG | — |
| 18691764 | SORBENTS AND METHODS FOR CARBON CAPTURE VIA CALCIUM LOOPING | HAILEY, PATRICIA L | — |
| 18288239 | ULTRA-STRONG HYDROGEL FIBERS | JONES, KOLTON ED | — |
| 18048339 | METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES | DIBRINO, MARIANNE | — |
| 17661873 | METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY | DIBRINO, MARIANNE | — |
| 17715796 | SYSTEMS AND METHODS FOR PREDICTING CARDIOTOXICITY OF MOLECULAR PARAMETERS OF A COMPOUND BASED ON MACHINE LEARNING ALGORITHMS | WOITACH, JOSEPH T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18026397 | METHODS OF TREATING AND/OR PREVENTING ALZHEIMER’S DISEASE WITH R-CARVEDILOL | JOHNSON, CHRISTOPHER LINDSAY | 66d overdue |
| 17532578 | NANOPARTICLES COMPRISING NON-CLASSICAL MHC AND USES THEREOF | SABILA, MERCY HELLEN | 19d overdue |
| 18744298 | SYSTEM AND METHOD FOR GLOBAL REAL-TIME KINEMATIC PRECISE POSITIONING | MOORE, WHITNEY | — |
| 18701047 | MICRONEEDLE AND ARRAY AND METHOD OF FABRICATING SAME | VU, QUYNH-NHU HOANG | — |
| 18691764 | SORBENTS AND METHODS FOR CARBON CAPTURE VIA CALCIUM LOOPING | HAILEY, PATRICIA L | — |
| 18048339 | METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES | DIBRINO, MARIANNE | — |
| 17661873 | METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY | DIBRINO, MARIANNE | — |
| 17715796 | SYSTEMS AND METHODS FOR PREDICTING CARDIOTOXICITY OF MOLECULAR PARAMETERS OF A COMPOUND BASED ON MACHINE LEARNING ALGORITHMS | WOITACH, JOSEPH T | — |
| Art Unit | Apps |
|---|---|
| 1641 | 2 |
| 3646 | 1 |
| 1763 | 1 |
| 1691 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18744298 | SYSTEM AND METHOD FOR GLOBAL REAL-TIME KINEMATIC PRECISE POSITIONING | MOORE, WHITNEY | 3646 | §101§102§103 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18701047 | MICRONEEDLE AND ARRAY AND METHOD OF FABRICATING SAME | VU, QUYNH-NHU HOANG | — | §102§103§112 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18691764 | SORBENTS AND METHODS FOR CARBON CAPTURE VIA CALCIUM LOOPING | HAILEY, PATRICIA L | — | §102§112 | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18290692 | METAL ORGANIC FRAMEWORK FILM AND METHOD OF MAKING | WITHERSPOON, SIKARL A | — | §103 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18288239 | ULTRA-STRONG HYDROGEL FIBERS | JONES, KOLTON ED | 1763 | §103§112 | Non-Final OA | — | Pending | Oct 25, 2023 |
| 18026397 | METHODS OF TREATING AND/OR PREVENTING ALZHEIMER’S DISEASE WITH R-CARVEDILOL | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §102§103§112 | Non-Final OA | 66d overdue | Pending | Mar 15, 2023 |
| 18048339 | METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES | DIBRINO, MARIANNE | 1641 | §103§112 | Final Rejection | — | Pending | Oct 20, 2022 |
| 17661873 | METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY | DIBRINO, MARIANNE | 1641 | §103§112 | Final Rejection | — | Pending | May 03, 2022 |
| 17715796 | SYSTEMS AND METHODS FOR PREDICTING CARDIOTOXICITY OF MOLECULAR PARAMETERS OF A COMPOUND BASED ON MACHINE LEARNING ALGORITHMS | WOITACH, JOSEPH T | — | §101§103 | Non-Final OA | — | Pending | Apr 07, 2022 |
| 17532578 | NANOPARTICLES COMPRISING NON-CLASSICAL MHC AND USES THEREOF | SABILA, MERCY HELLEN | 1654 | §103 | Final Rejection | 19d overdue | Pending | Nov 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial